Skip to main navigation
Skip to search
Skip to main content
Research @ Flinders Home
Home
Profiles
Research Units
Research Outputs
Projects
Prizes
Activities
Equipment
Search by expertise, name or affiliation
Idraparinux versus standard therapy for venous thromboembolic disease
The van Gogh Investigators
Research output
:
Contribution to journal
›
Article
›
peer-review
316
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Idraparinux versus standard therapy for venous thromboembolic disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Idraparinux
100%
Heparin
30%
Deep Vein Thrombosis
30%
Antivitamin K
30%
Lung Embolism
30%
Recurrent Disease
20%
Retinol
20%
Noninferiority Trial
10%
Bleeding
10%
Blood Clotting Factor 10
10%
Low Molecular Weight Heparin
10%